Companies → Yifeng Pharmacy Chain Co., Ltd.
Save to list
Remove

Yifeng Pharmacy Chain Co., Ltd.

China, Hunan, Changsha
Description
by AI
Yifeng Pharmacy Chain Co, Ltd. is a pharmaceutical company that provides wholesale and distribution services for drugs, medical devices and other healthcare products. The company is headquartered in Changsha, Hunan Province, China. Yifeng Pharmacy Chain has a network of over 1,000 retail pharmacies and clinics across China. The company also provides online sales of pharmaceuticals and healthcare products through its website and mobile app. Yifeng Pharmacy Chain is a leading pharmaceutical company in China and is committed to providing high-quality healthcare products and services to its customers.
Address:

No.68

Jinzhou Avenue

High-Tech Zone

Yuelu District Changsha

Hunan

410000 China

Website:
Revenue
Recent news:

Top Dividend Stocks In Global For September 2025

As global markets navigate a complex landscape marked by weaker-than-expected U.S. labor data and shifting interest rate expectations, investors are keenly observing economic indicators for signs of stability or further volatility. In this environment, dividend stocks can offer a measure of resilience and income potential, making them an attractive option for those looking to balance growth with steady returns.

Source: Simply Wall St. Sep 8, 2025

SZSE - Delayed Quote - CNY
603939.SS
24.45 +0.62 (+2.60%)
At close March 23 07:00 UTC
Candle
Line
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 29.64 B
Enterprise Value: 26.23 B
Trailing P/E: 18.66
Forward P/E: 14.21
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 1.27
Price/Book (mrq): 2.65
Enterprise Value/Revenue: 1.09
Enterprise Value/EBITDA: 10.18
Financial Highlights
Profitability and Income Statement
Profit Margin: 6.81%
Return on Assets (ttm): 5.58%
Return on Equity (ttm): 15.59%
Revenue (ttm): 24.13 B
Net Income Avi to Common (ttm): 1.64 B
Diluted EPS (ttm): 1.31
Balance Sheet and Cash Flow
Total Cash (mrq): 8.11 B
Total Debt/Equity (mrq): 39.59%
Levered Free Cash Flow (ttm): 1.42 B
Company is likely to buy
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.